Reference: 1180 Title: The High Cost of Cancer Drugs and What We Can Do About It Summary: The high cost of cancer drugs persists due to strong demand from patients and physicians, which diminishes the incentive for companies to lower prices. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538397